$29M sweet spot round size
Most of their 381 investments are in rounds between $13M and $55M
1986
Lightcast Discovery raised $49M on August 17, 2023
Investors: LONGWALL VENTURE PARTNERS LLP, OMX Ventures, Illumina Ventures, M Ventures and ARCH Venture Partners
Undisclosed raised $145M on June 7, 2023
Investors: Koch Disruptive Technologies, GV and ARCH Venture Partners
OncoResponse Inc. raised $14M on May 18, 2023
Investors: RiverVest Venture Partners, INTERVEST-Mortgage Investment Co., 3B Future Health Fund, Canaan, Takeda UK Limited, Bering Capital and ARCH Venture Partners
Myeloid Therapeutics raised $73M on May 18, 2023
Investors: Newpath Partners, 8VC and ARCH Venture Partners
Orbital Therapeutics raised $270M on April 26, 2023
Investors: Heritage Medical Systems, Newpath Partners, Redmile Group, Casdin Capital, LLC, Exor N.V., iGlobe Partners, The Invus Group and ARCH Venture Partners
Recuro Health raised $47M on April 11, 2023
Investors: The Flippen Group, 4D Capital and ARCH Venture Partners
Rapport Therapeutics raised $100M on March 7, 2023
Investors: Third Rock Ventures and ARCH Venture Partners
Volastra Therapeutics raised $60M on March 7, 2023
Investors: Polaris Partners, -, Catalio Capital Management, Vida Ventures, LLC and ARCH Venture Partners
Paratus Sciences raised $100M on February 27, 2023
Investors: ClavystBio, Polaris Partners, Leaps by Bayer and ARCH Venture Partners
IngredientWerks raised undisclosed on February 15, 2023
Investors: Open Prairie Ventures and ARCH Venture Partners